Abstract: This invention relates to certain quinoline-diaryl compounds and their use as leukotriene D.sub.4 antagonists for the treatment of hypersensitive disorders.
Type:
Grant
Filed:
November 3, 1987
Date of Patent:
April 24, 1990
Assignee:
Rorer Pharamceutical Corp.
Inventors:
Fu-chi Huang, Robert A. Galemmo, Jr., Henry F. Campbell